# Intermittent Use of Aerosolized Ribavirin for Treatment of RSV

> **NCT00500578** · PHASE4 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 51 (actual)

## Conditions studied

- Hematological Malignancies

## Interventions

- **DRUG:** Ribavirin
- **DRUG:** Ribavirin

## Key facts

- **NCT ID:** NCT00500578
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2012-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00500578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00500578, "Intermittent Use of Aerosolized Ribavirin for Treatment of RSV". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00500578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*